Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 10/2012

01.10.2012 | Article

Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh

verfasst von: M. A. Islam, P. K. Talukdar, A. Hoque, M. Huq, A. Nabi, D. Ahmed, K. A. Talukder, M. A. C. Pietroni, J. P. Hays, A. Cravioto, H. P. Endtz

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 10/2012

Einloggen, um Zugang zu erhalten

Abstract

The main objective of this study was to investigate the prevalence of bla NDM-1 in Gram-negative bacteria in Bangladesh. In October 2010 at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) laboratories, 1,816 consecutive clinical samples were tested for imipenem-resistant Gram-negative organisms. Imipenem-resistant isolates were tested for the bla NDM-1 gene. Among 403 isolates, 14 (3.5 %) were positive for bla NDM-1, and the predominant species were Klebsiella pneumoniae, Acinetobacter baumannii, and Escherichia coli. All bla NDM-1-positive isolates were resistant to multiple antibiotics. Among β-lactamase genes, bla CTX-M-1-group was detected in ten isolates (eight bla CTX-M-15), bla OXA-1-group in six, bla TEM in nine, bla SHV in seven, and bla VIM and bla CMY in two isolates each. The 16S rRNA methylase gene, armA, was detected in five K. pneumoniae isolates and in one E. coli isolate. rmtB and rmtC were detected in a Citrobacter freundii and two K. pneumoniae isolates, respectively. qnr genes were detected in two K. pneumoniae isolates (one qnrB and one qnrS) and in an E. coli isolate (qnrA). Transferable plasmids (60–100 MDa) carrying bla NDM-1 were detected in 7 of the 11 plasmid-containing isolates. Pulsed-field gel electrophoresis (PFGE) analysis grouped K. pneumoniae isolates into three clusters, while E. coli isolates differed significantly from each other. This study reports that approximately 3.5 % of Gram-negative clinical isolates in Bangladesh are NDM-1-producing.
Literatur
1.
Zurück zum Zitat Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602PubMedCrossRef Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, Woodford N (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602PubMedCrossRef
2.
Zurück zum Zitat Bush K, Jacoby GA (2010) Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54:969–976PubMedCrossRef Bush K, Jacoby GA (2010) Updated functional classification of β-lactamases. Antimicrob Agents Chemother 54:969–976PubMedCrossRef
3.
Zurück zum Zitat Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR (2009) Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054PubMedCrossRef Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR (2009) Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054PubMedCrossRef
4.
Zurück zum Zitat Muir A, Weinbren MJ (2010) New Delhi metallo-β-lactamase: a cautionary tale. J Hosp Infect 75:239–240PubMedCrossRef Muir A, Weinbren MJ (2010) New Delhi metallo-β-lactamase: a cautionary tale. J Hosp Infect 75:239–240PubMedCrossRef
5.
Zurück zum Zitat Clinical and Laboratory Standard Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; 20th Informational Supplement (June 2010 update) M100-S20-U. CLSI, Wayne Clinical and Laboratory Standard Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; 20th Informational Supplement (June 2010 update) M100-S20-U. CLSI, Wayne
6.
Zurück zum Zitat Frye JG, Fedorka-Cray PJ (2007) Prevalence, distribution and characterisation of ceftiofur resistance in Salmonella enterica isolated from animals in the USA from 1999 to 2003. Int J Antimicrob Agents 30:134–142PubMedCrossRef Frye JG, Fedorka-Cray PJ (2007) Prevalence, distribution and characterisation of ceftiofur resistance in Salmonella enterica isolated from animals in the USA from 1999 to 2003. Int J Antimicrob Agents 30:134–142PubMedCrossRef
7.
Zurück zum Zitat Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH (2005) Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 56:698–702PubMedCrossRef Ryoo NH, Kim EC, Hong SG, Park YJ, Lee K, Bae IK, Song EH, Jeong SH (2005) Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 56:698–702PubMedCrossRef
8.
Zurück zum Zitat Guerra B, Soto SM, Argüelles JM, Mendoza MC (2001) Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-]. Antimicrob Agents Chemother 45:1305–1308PubMedCrossRef Guerra B, Soto SM, Argüelles JM, Mendoza MC (2001) Multidrug resistance is mediated by large plasmids carrying a class 1 integron in the emergent Salmonella enterica serotype [4,5,12:i:-]. Antimicrob Agents Chemother 45:1305–1308PubMedCrossRef
9.
Zurück zum Zitat Muzaheed, Doi Y, Adams-Haduch JM, Endimiani A, Sidjabat HE, Gaddad SM, Paterson DL (2008) High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 61:1393–1394PubMedCrossRef Muzaheed, Doi Y, Adams-Haduch JM, Endimiani A, Sidjabat HE, Gaddad SM, Paterson DL (2008) High prevalence of CTX-M-15-producing Klebsiella pneumoniae among inpatients and outpatients with urinary tract infection in Southern India. J Antimicrob Chemother 61:1393–1394PubMedCrossRef
10.
Zurück zum Zitat Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119–123PubMedCrossRef Poirel L, Walsh TR, Cuvillier V, Nordmann P (2011) Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119–123PubMedCrossRef
11.
Zurück zum Zitat Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88–94PubMedCrossRef Doi Y, Arakawa Y (2007) 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45:88–94PubMedCrossRef
12.
Zurück zum Zitat Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394–397PubMedCrossRef Cattoir V, Poirel L, Rotimi V, Soussy CJ, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemother 60:394–397PubMedCrossRef
13.
Zurück zum Zitat Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353PubMedCrossRef Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM (2006) Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353PubMedCrossRef
14.
Zurück zum Zitat Talukder KA, Islam MA, Dutta DK, Hassan F, Safa A, Nair GB, Sack DA (2002) Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. J Clin Microbiol 40:2490–2497PubMedCrossRef Talukder KA, Islam MA, Dutta DK, Hassan F, Safa A, Nair GB, Sack DA (2002) Phenotypic and genotypic characterization of serologically atypical strains of Shigella flexneri type 4 isolated in Dhaka, Bangladesh. J Clin Microbiol 40:2490–2497PubMedCrossRef
15.
Zurück zum Zitat Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ (2006) Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3:59–67PubMedCrossRef Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, Barrett TJ (2006) Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3:59–67PubMedCrossRef
16.
Zurück zum Zitat Rolain JM, Parola P, Cornaglia G (2010) New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect 16:1699–1701PubMedCrossRef Rolain JM, Parola P, Cornaglia G (2010) New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect 16:1699–1701PubMedCrossRef
17.
Zurück zum Zitat Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P (2010) Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 54:4914–4916PubMedCrossRef Poirel L, Lagrutta E, Taylor P, Pham J, Nordmann P (2010) Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 54:4914–4916PubMedCrossRef
18.
Zurück zum Zitat Poirel L, Dortet L, Bernabeu S, Nordmann P (2011) Genetic features of bla NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 55:5403–5407PubMedCrossRef Poirel L, Dortet L, Bernabeu S, Nordmann P (2011) Genetic features of bla NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 55:5403–5407PubMedCrossRef
19.
Zurück zum Zitat Poirel L, Ros A, Carricajo A, Berthelot P, Pozzetto B, Bernabeu S, Nordmann P (2011) Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–448PubMedCrossRef Poirel L, Ros A, Carricajo A, Berthelot P, Pozzetto B, Bernabeu S, Nordmann P (2011) Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–448PubMedCrossRef
20.
Zurück zum Zitat Birgy A, Doit C, Mariani-Kurkdjian P, Genel N, Faye A, Arlet G, Bingen E (2011) Early detection of colonization by VIM-1 producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol 49:3085–3087PubMedCrossRef Birgy A, Doit C, Mariani-Kurkdjian P, Genel N, Faye A, Arlet G, Bingen E (2011) Early detection of colonization by VIM-1 producing Klebsiella pneumoniae and NDM-1-producing Escherichia coli in two children returning to France. J Clin Microbiol 49:3085–3087PubMedCrossRef
21.
Zurück zum Zitat Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P (2012) Tn125-related acquisition of bla NDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother 56:1087–1089PubMedCrossRef Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P (2012) Tn125-related acquisition of bla NDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother 56:1087–1089PubMedCrossRef
22.
Zurück zum Zitat Okeke IN, Lamikanra A, Edelman R (1999) Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 5:18–27PubMedCrossRef Okeke IN, Lamikanra A, Edelman R (1999) Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis 5:18–27PubMedCrossRef
Metadaten
Titel
Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh
verfasst von
M. A. Islam
P. K. Talukdar
A. Hoque
M. Huq
A. Nabi
D. Ahmed
K. A. Talukder
M. A. C. Pietroni
J. P. Hays
A. Cravioto
H. P. Endtz
Publikationsdatum
01.10.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 10/2012
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1601-2

Weitere Artikel der Ausgabe 10/2012

European Journal of Clinical Microbiology & Infectious Diseases 10/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.